IRIS
SARNELLI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.404
AS - Asia 11.403
EU - Europa 8.319
SA - Sud America 1.282
Continente sconosciuto - Info sul continente non disponibili 498
AF - Africa 297
OC - Oceania 91
Totale 34.294
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.876
SG - Singapore 4.779
RU - Federazione Russa 3.031
IT - Italia 2.186
CN - Cina 2.140
VN - Vietnam 1.978
BR - Brasile 1.030
HK - Hong Kong 885
DE - Germania 586
FR - Francia 488
FI - Finlandia 346
IE - Irlanda 331
UA - Ucraina 318
BD - Bangladesh 310
IN - India 284
GB - Regno Unito 265
JP - Giappone 265
CA - Canada 259
NL - Olanda 241
MX - Messico 147
SE - Svezia 108
PL - Polonia 99
AR - Argentina 90
PH - Filippine 86
AU - Australia 80
ES - Italia 79
ID - Indonesia 79
KR - Corea 77
ZA - Sudafrica 74
IQ - Iraq 70
TR - Turchia 68
CI - Costa d'Avorio 66
TH - Thailandia 56
PK - Pakistan 51
EC - Ecuador 49
TW - Taiwan 43
SA - Arabia Saudita 37
AT - Austria 34
CO - Colombia 31
BE - Belgio 30
VE - Venezuela 28
JM - Giamaica 27
RO - Romania 26
LT - Lituania 24
MA - Marocco 24
UZ - Uzbekistan 22
EG - Egitto 21
MY - Malesia 21
ET - Etiopia 20
NP - Nepal 18
TN - Tunisia 18
IL - Israele 17
CZ - Repubblica Ceca 16
GR - Grecia 16
JO - Giordania 16
KE - Kenya 16
AE - Emirati Arabi Uniti 15
DZ - Algeria 15
PT - Portogallo 15
CR - Costa Rica 14
TT - Trinidad e Tobago 14
CL - Cile 13
PE - Perù 13
PY - Paraguay 12
RS - Serbia 12
AZ - Azerbaigian 11
NZ - Nuova Zelanda 11
HN - Honduras 10
IR - Iran 10
LB - Libano 10
OM - Oman 9
UY - Uruguay 9
BB - Barbados 8
EU - Europa 8
CH - Svizzera 7
GT - Guatemala 7
HR - Croazia 7
NI - Nicaragua 7
PA - Panama 7
DO - Repubblica Dominicana 6
KZ - Kazakistan 6
MD - Moldavia 6
PR - Porto Rico 6
SN - Senegal 6
BO - Bolivia 5
BY - Bielorussia 5
MT - Malta 5
QA - Qatar 5
SK - Slovacchia (Repubblica Slovacca) 5
AM - Armenia 4
DK - Danimarca 4
GA - Gabon 4
LK - Sri Lanka 4
MK - Macedonia 4
SV - El Salvador 4
AL - Albania 3
AO - Angola 3
BG - Bulgaria 3
BH - Bahrain 3
HU - Ungheria 3
Totale 33.720
Salva come PNG Salva come JPEG
Città #
Singapore 2.248
San Jose 1.365
Hong Kong 851
Ashburn 798
Chandler 739
Moscow 735
Beijing 573
Ho Chi Minh City 502
Santa Clara 468
Hanoi 442
Naples 362
Jacksonville 319
Los Angeles 302
Hefei 280
Millbury 263
The Dalles 258
Lauterbourg 250
Tokyo 230
New York 216
Princeton 206
Napoli 203
Council Bluffs 201
Nanjing 169
Dallas 163
Dong Ket 156
Amsterdam 151
Boston 149
Munich 147
Buffalo 145
Rome 125
Milan 115
Wilmington 107
São Paulo 106
Atlanta 104
Dearborn 99
Des Moines 85
Houston 85
Denver 83
Orem 76
Warsaw 75
Da Nang 74
Redondo Beach 73
Frankfurt am Main 71
Seattle 69
Mexico City 65
Ottawa 65
Menlo Park 64
Montreal 61
London 60
Haiphong 58
Turku 58
Woodbridge 58
San Francisco 54
Chicago 52
Nanchang 52
Phoenix 51
Hebei 49
Lappeenranta 49
Seoul 49
Mumbai 48
Brooklyn 47
Chennai 47
Dublin 46
Helsinki 44
Shenyang 44
Nuremberg 41
Toronto 39
Boardman 38
Tianjin 37
Kronberg 36
Lawrence 36
Stockholm 36
Falkenstein 34
Hải Dương 34
Poplar 32
Redwood City 31
Bangkok 30
Changsha 30
Johannesburg 30
Melbourne 30
Rio de Janeiro 30
Bologna 29
Baghdad 27
Falls Church 27
Quito 27
Shanghai 27
Jakarta 26
Guangzhou 25
Pune 25
Curitiba 24
Norwalk 24
Palermo 24
Belo Horizonte 23
Can Tho 23
Jiaxing 23
Biên Hòa 22
Dhaka 22
Turin 22
Manchester 21
Thái Nguyên 20
Totale 16.364
Salva come PNG Salva come JPEG
Nome #
Effects of oral supplementation with the symbiotic (bifidobacterium longum w11 + fos actilight) on IBS with constipation: a randomized, dose finding trial, versus fibers, 620
Effects of carbonated water on functional dyspepsia and constipation. 543
Sweetened carbonated drinks do not alter upper digestive tract physiology in healthy subjects 493
Postprandial Gastrointestinal Function Differs after Acute Administration of Sourdough Compared with Brewer's Yeast Bakery Products in Healthy Adults 472
Italian guidelines for the diagnosis and management of gastro-esophageal reflux disease: Joint consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), and General Medicine (SIMG) 441
La dispepsia post-infettiva: evoluzione sintomatologica- funzionale, predisposizione genetica, ruolo dell'Ossido Nitrico Sintetasi inducibile e coinvolgimento della glia entererica. 369
Effect of carbonated drinks on upper digestive tract sensations and physiology in healthy subjects. 365
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis. 324
Altered taste perception in patients with gastroesophagealreflux disease 259
The potential of cannabidiol in the COVID‐19 pandemic. 245
Intrarectal Administration of Adelmidrol plus Hyaluronic Acid Gel Ameliorates Experimental Colitis in Mice and Inhibits Pro-Inflammatory Response in Ex Vivo Cultured Biopsies Derived from Ulcerative Colitis-Affected Patients 237
Frequency, Symptoms Evolution and Pathophysiological Correlates in Prospectively Identified Patients With Postinfectious Dyspepsia 237
Carbonated beverages and gastrointestinal system: between myth and reality 234
ADHERENCE TO MEDITERRANEAN DIET AND IBS SYMPTOMS IN ADOLESCENTS 229
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry 227
Mild dehydration in dyspeptic athletes is able to increase gastrointestinal symptoms: Protective effects of an appropriate hydration 224
ALLELE-SPECIFIC TRANSCRIPTIONAL ACTIVITY OF THE VARIABLE NUMBER OF TANDEM REPEATS OF THE INDUCIBLE NITRIC OXIDE SYNTHASE GENE IS ASSOCIATED WITH IDIOPATHIC ACHALASIA 202
Sleeve gastrectomy-induced weight loss in severe obesity did not modify perception, intensity and pleasantness of basic tastes 197
Detection of colonic dysplasia in patients with ulcerative colitis using a targeted fluorescent peptide and confocal laser endomicroscopy: A pilot study 192
Role of Non-Caloric Carbonated Beverage Preload During a Standardized Solid and Liquid Meal on Colecistokinin and Ghrelin Levels in Healthy Subjects 190
Clinical and nutritional correlates associated with weight changes in achalasia patients and the impact of laparoscopic Heller myotomy 185
Effects of long-term PPI treatment on producing bowel symptoms and SIBO 179
Oleoylethanolamide-producing Lactobacillus paracasei F19 improves metabolic and behavioral disorders by restoring intestinal permeability and microbiota-gut-brain axis in high-fat diet-induced obese male mice 178
Enteric Glia Stimulates Inflammation-Induced Responses in Human Intestine and Interacts with Immune Cells via S100B Protein 169
Bacterial stimuli activate nitric oxide colonic mucosal production in diverticular disease. Protective effects ofL. casei DG® (Lactobacillus paracaseiCNCM I-1572) 168
SPECIFIC DYSPEPTIC SYMPTOMS ARE ASSOCIATED WITH POOR RESPONSE TO THERAPY IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE 166
Nasogastric tube after laparoscopic Heller-Dor surgery: Do you really need it? 161
The astroglial-derived S100 Beta protein stimulates the expression of nitric oxide synthase in rodent macrophages through p38 MAP kinase activation. 160
Eosinophilic esophagitis: From pathophysiology to treatment. 160
Partially hydrolyzed guar gum in the treatment of irritable bowel syndrome with constipation: effects of gender, age, and body mass index 160
The role of a pre-load beverage on gastric volume and food intake: comparison between non-caloric carbonated andnon-carbonated beverage 158
EARLY CHANGES IN HRM-OESOPHAGEAL PARAMETERS IN PRE AND POST TREATMENT ACHALASIA PATIENTS 158
Preservation of the inferior mesenteric artery VS ligation of the inferior mesenteric artery in left colectomy: evaluation of functional outcomes-a prospective non-randomized controlled trial 157
Palmitoylethanolamide Exerts Antiproliferative Effect and Downregulates VEGF Signaling in Caco-2 Human Colon Carcinoma Cell Line Through a Selective PPAR-α-Dependent Inhibition of Akt/mTOR Pathway 155
CHRONIC CONSTIPATION IS A RISK FACTOR FOR METABOLIC SYNDROME 155
Long-Term Functional Results of a Modified Caudal-to-Cranial Approach in Laparoscopic Segmental Left Colectomy for Diverticular Disease 155
Probiotic and Postbiotic Effects of Lactobacillus Casei DG on Enteroglial-Derived S100B and Nitric Oxide Production in Human Intestinal Biopsies 154
Clinical correlation and disease phenotype in patients with esophageal achalasia and comorbid autoimmune diseases 154
Impaired duodenal Palmitoylethanolamide release underlies acid-induced mast cells activation in Functional Dyspepsia 153
Beneficial Effects on Exercise Capacity Associated with a Combination of Lactoferrin, Lysozyme, Lactobacillus, Resveratrol, Vitamins, and Oligoelements in Patients with Post-COVID-19 Syndrome: A Single-Center Retrospective Study 152
Robotic versus laparoscopic approach to treat symptomatic achalasia: systematic review with meta-analysis 151
PHENYLTHIOCARBAMIDE TASTING STATUS AFFECTS QUININE-MEDIATED REDUCTION OF FOOD INTAKE 151
Impact of psychological distress and psychophysical wellbeing on posttraumatic symptoms in parents of preterm infants after NICU discharge 150
Endoscopic treatment of esophageal achalasia 150
Rifaximin improves Clostridium difficile toxin A-induced toxicity in Caco-2 cells by the PXR-dependent TLR4/MyD88 /NF-?B pathway 150
S100B protein in the gut: the evidence for enteroglial-sustained intestinal inflammation. 148
TASTE DISORDERS IN PATIENTS WITH GASTROESOPHAGEALREFLUX DISEASE 148
Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice 147
ACETONIC EXTRACT FROM FEIJOA SELLOWIANA BERG.FRUITS INHIBITS PROLIFERATION, MODULATES BRUSH BORDERMEMBRANE ENZYMES ACTIVITIES AND PREVENT LIPID PEROXIDATIONIN HUMAN INTESTINAL EPITHELIAL CELLS 145
Impaired post-reflux swallow-induced peristaltic wave in severe obesity and implication in esophageal hyposensitivity 145
Cannabidiol restores intestinal barrier dysfunction and inhibits the apoptotic process induced by Clostridium difficile toxin A in Caco-2 cells 145
Next-Generation Probiotics for Inflammatory Bowel Disease 144
Body position may change high resolution manometry parameters and drift therapeutic choice in achalasia patients 144
HIV-1 Tat-induced diarrhea is improved by the PPARalpha agonist, palmitoylethanolamide, by suppressing the activation of enteric glia 144
Diet and functional dyspepsia: Clinical correlates and therapeutic perspectives 143
Acetonic Extract from the Feijoa sellowiana Berg. Fruit Exerts Antioxidant Properties and Modulates Disaccharidases Activities in Human Intestinal Epithelial Cells 141
The bitter taste receptor agonist quinine reduces calorie intake and increases the postprandial release of cholecystokinin in healthy subjects 141
Nutraceuticals and Diet Supplements in Crohn's Disease: A General Overview of the Most Promising Approaches in the Clinic 141
Effect of Dewaxed Coffee on Gastroesophageal Symptoms in Patients with GERD: A Randomized Pilot Study 141
Effect of enteroglial-derived S100B protein on human peripheral and mucosal immune cells’ functions 140
Esophageal sensitivity and impaired post-reflux swallow-induced peristaltic wave are dependent by body mass index and acid exposition 140
N-Palmitoyl-D-Glucosamine Inhibits TLR-4/NLRP3 and Improves DNBS-Induced Colon Inflammation through a PPAR-α-Dependent Mechanism 139
Esophageal Acid Exposure and Altered Neurocardiac Function in Patients with GERD and Idiopatic Cardiac Arrhythmias 138
GERD IS A PROTECTIVE RISK FACTOR FOR HYPERTENSION 138
ACHALASIA TREATMENT IMPROVES SPECIFIC SYMPTOMS AND QUALITY OF LIFE: VALIDATION OF AN ACHALASIA SPECIFIC QUALITY OF LIFE QUESTIONNAIRE 137
Author's reply: “Nutritional evaluations and post-treatment strategies in Achalasia” 136
DOES STANDARDIZED DIET IMPROVE PROTON PUMP INHIBITOR RESPONSE IN GERD PATIENTS? 136
Gastro-duodenal lesions and Helicobacter pylori infection in dyspeptic patients with and without chronic renal failure 135
BITTER TASTE RECEPTOR AGONIST AFFECTS FOOD INTAKEIN HEALTHY SUBJECTS 135
La proteina di derivazione enterogliale S100B stimola la produzione di ossido nitrico nella colite ulcerosa. 134
PPI general practitioners’prescribing in the treatment of acid-related disorders: the impact of generic PPI launch into the pharmaceutical market in Italy 134
THE MEDITERRANEAN DIET IS A PROTECTIVE FACTOR AGAINST GASTROINTESTINAL SYMPTOMS IN YOUNG PEOPLE 134
Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner 133
Ketogal: A Derivative Ketorolac Molecule with Minor Ulcerogenic and Renal Toxicity 133
Cortical representation of different taste modalities on the gustatory cortex: A pilot study 133
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis – Definition, Clinical Presentation and Diagnosis 133
THE ENTEROGLIAL DERIVED-S100B PROTEIN MEDIATES THEPROTECTIVE EFFECT OF LACTOBACILLUS CASEI DG ON LPS-INDUCEDNITRIC OXIDE PRODUCTION IN HUMAN INTESTINAL BIOPSIES 132
CORRELATES TO ABDOMINAL PAIN IN CONSTIPATION PREVALENT IBS PATIENTS 132
CO2 modulates the central neural processing of sweet perception: an fMRI study 132
Enteric glia: A new player in inflammatory bowel diseases 132
Laparoscopic Heller-Dor myotomy in elderly achalasia patients: a single center experience with PSM analysis 131
Enteric Glial Protein S100b Up-Regulation Stimulates Nitric Oxide Production in Ulcerative Colitis. 131
6 months-treatment of symptomatic uncomplicated diverticular disease of the colon with Lactobacillus paracasei F19 131
Effect of enteroglial-derived S100B protein on proliferation and responses in human peripheral and mucosal immune cells 131
Rationale and evidences for treatment of symptomatic uncomplicated diverticular disease 131
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis–Current Treatment and Monitoring 130
Predictors of abdominal pain severity in patients with constipation-prevalent irritable bowel syndrome 130
Engineered Lactobacillus paracasei Producing Palmitoylethanolamide (PEA) Prevents Colitis in Mice 130
Autoimmune comorbidities in idiopathic achalasia 129
PARTIALLY HYDROLYZED GUAR GUM (PHGG) IN THE TREATMENT OF IRRITABLE BOWEL SYNDROME (IBS) WITH CONSTIPATION: EFFECTS OF GENDER, AGE AND BODY MASS INDEX (BMI) 128
Genetic contribution to motility disorders of the upper gastrointestinal tract. 128
S100B Protein Stimulates Proliferation and Angiogenic Mediators Release through RAGE/pAkt/mTOR Pathway in Human Colon Adenocarcinoma Caco-2 Cells 127
Rifaximin, a non-absorbable antibiotic, inhibits the release of pro-angiogenic mediators in colon cancer cells through a pregnane X receptor-dependent pathway. 127
Proton pump inhibitors prescribing following the introduction of generic drugs 125
Lathyrus sativus diamine oxidase counteracts histamine-induced cell proliferation, migration and pro-angiogenic mediators release in human colon adenocarcinoma cell line Caco-2 125
Oral Immunization with Escherichia coli Nissle 1917 Expressing SARS-CoV-2 Spike Protein Induces Mucosal and Systemic Antibody Responses in Mice 124
Association between ccttt pentanucleotide repeat in the inducible nitric oxide synthase promoter polymorphism and achalasia 124
Irritable bowel syndrome and food interaction. 124
Phytotherapics in COVID19: Why palmitoylethanolamide? 124
THE ENTEROGLIAL-DERIVED S100B PROTEIN CONTROLSHUMAN INTESTINAL EPITHELIAL CELLS DIFFERENTIATION ANDPROLIFERATION VIA RAGE INTERACTION 123
Totale 17.695
Salva come PNG Salva come JPEG
Categoria #
all - tutte 104.456
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.456
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.434 0 18 5 18 23 72 24 43 271 82 323 555
2022/20231.729 264 148 45 127 204 208 25 156 263 148 109 32
2023/20241.604 48 191 189 143 71 119 74 173 70 92 264 170
2024/20257.520 402 467 59 92 241 454 725 471 649 762 2.559 639
2025/202615.605 1.635 934 1.373 1.534 2.434 660 1.642 1.061 1.882 1.195 600 655
2026/20272.791 1.914 877 0 0 0 0 0 0 0 0 0 0
Totale 34.294